Electrochemotherapy with Carboplatinum plus Bleomycin versus Bleomycin alone in vulvar cancer: the ElechtraPlatinum Study. A Randomized Controlled Trial

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518370-14-00

Acronym

ElechtraPlatinum

Enrollment

Registered

2024-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

relapsing vulvar carcinoma already subjected to multiple treatments

Brief summary

local progression free survival

Interventions

DRUGBLEOPRIM 15 mg polvere per soluzione iniettabile

DRUGCarboplatino AHCL 10 mg/ml Concentrato per soluzione per infusione

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
local progression free survival	—

Countries

Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026